 |
|
 |
|
  |
|
|
New travel vaccines can add to the plethora of already licensed vaccines for this established market segment. Despite the 2020 SARS-CoV-2 [COVID-19] significantly affecting air and cruise travel, upon
market recovery, there remains a good business case for development in this area. New chikungunya virus and diarrheal diseases (Shigellosis, Campylobacter, norovirus and ETEC) are well positioned.
MarketVIEW products in the travel vaccines segment are available for the following areas. Please click on the tablets below:
***Summer 2020*** New 'snap shot' analyses containing a disease profile and a single country revenue forecast can now be ordered across the range.
*For more information about this product and how to order,
e-mail: orders@vaczine-analytics.com
For UK orders VAT will be added at 20%. TERMS and CONDITIONS of purchase will be made available upon enquiry.
| Documents on this page are available in Portable Document Format (PDF) 
|
|
|
|
|
|
